Qingfeng Yu

机构：Neijiang Normal University, First Affiliated Hospital of Chinese PLA General Hospital · ORCID：0000-0001-7316-627X

发表论文 73 篇 · 总被引 636 次 · h-index 17

代表论文

• Inhibition of LIM kinase reduces contraction and proliferation in bladder smooth muscle (2021 · Acta Pharmaceutica Sinica B · 被引 20)
• NEAT1/MALAT1/XIST/PKD--Hsa-Mir-101-3p--DLGAP5 Axis as a Novel Diagnostic and Prognostic Biomarker Associated With Immune Cell Infiltration in Bladder Cancer (2022 · Frontiers in Genetics · 被引 19)
• Editorial: Benign prostatic hyperplasia and overactive bladder: new members of metabolic syndrome (2023 · Frontiers in Urology · 被引 7)
• Phosphoproteomics identifies potential downstream targets of the integrin α2β1 inhibitor BTT-3033 in prostate stromal cells (2021 · Annals of Translational Medicine · 被引 6)
• Prognostic value of circulating plasma cells detected by flow cytometry in newly diagnosed multiple myeloma patients: a systematic review and meta-analysis (2024 · BMJ Open · 被引 5)
• Design, Synthesis, and Evaluation of Novel Isoxazoline Derivatives as Potent GABA Receptor Modulators (2025 · Journal of Agricultural and Food Chemistry · 被引 4)